Clinical Trials Browser

Phase 2 × Uterine Cervical Dysplasia × GX-188 vaccine × Clear all

NCT02139267 2017-07-12

Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

Phase 2 Completed

Uterine Cervical Dysplasia, Genital Diseases, Female, Neoplasms, Uterine Diseases, Papillomavirus Infections

NCT02596243 2017-07-12

Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)

Phase 2 Unknown

Uterine Cervical Dysplasia, Papillomavirus Infections